PRELUDE CAPITAL MANAGEMENT, LLC
Position in WHWK — Whitehawk Therapeutics, Inc.
CIK 1387508
NEW YORK, NY
Position in WHWK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$35,476
-$10,010 QoQ
Shares Held
10,283
-45.3% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
10 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in WHWK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $43,640,056 across 72 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | 58,590 | $7,776,650 | |||
| 2 | TECH |
BIO-TECHNE Corp
|
91,696 | $6,478,322 | |
| 3 | PGEN |
Precigen, Inc.
|
882,267 | $5,028,921 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
113,104 | $4,002,750 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
10,997 | $2,059,518 | |
| 6 | TWST |
Twist Bioscience Corp
|
18,976 | $1,952,250 | |
| 7 | QURE |
uniQure N.V.
|
32,229 | $1,484,467 | |
| 8 | MDXG |
Mimedx Group, Inc.
|
215,239 | $828,670 |
All Filings in WHWK
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35,476 | 10,283 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $45,486 | 18,796 | Shares | Other | 2026-02-17 | |
| 2025-03-31 | $18,150 | 10,197 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $40,690 | 12,897 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $36,661 | 17,797 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $52,847 | 36,197 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $85,636 | 36,597 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $53,321 | 26,397 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $105,981 | 21,897 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $75,746 | 11,074 | Shares | Other | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||